MongoDB, Inc. is a New York-based database software company best known for its document-oriented NoSQL database and its multi-cloud database-as-a-service offering, Atlas. Atlas, which now accounts for roughly three-quarters of total revenue, lets customers run, scale, and manage databases across major public clouds. The company also sells Enterprise Advanced for on-premises and hybrid deployments and has expanded into search, vector search, and embeddings through its Voyage AI technology. MongoDB competes for a share of a market historically dominated by Oracle (ORCL) and Microsoft (MSFT), and it positions itself as a data platform for modern, AI-enabled application development. From what I see, this positioning remains central to how the company differentiates itself in a competitive landscape.
Over the last 30 days, MDB declined roughly 23.3%, falling from $472.29 on August 13, 2026, to $362.21 on September 11, 2026. The decline was concentrated around the company's fiscal second-quarter earnings release: after closing at $434.21 on September 1, shares fell about 13.5% to $375.40 the following session and continued drifting lower in the days after. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The longer-term picture is more mixed. Over the last quarter, MDB is still up about 5.7%, rising from $342.80 on June 12, 2026. That quarterly gain reflects a powerful summer rally: the stock bottomed near $294 in late June before climbing more than 60% to a peak close of $472.29 in mid-August, just below its 52-week intraday high of $473.10. The September earnings reaction erased a meaningful portion of that advance, leaving the quarter's net gain modest despite the sharp swing in both directions.
The primary catalyst was MongoDB's fiscal 2027 second-quarter report, released on September 1, 2026. The headline results were strong: revenue grew 30.5% year over year to $771.8 million, ahead of the roughly $735 million consensus, and adjusted earnings per share reached $1.90 versus the $1.61 expected. Free cash flow nearly doubled to $137.6 million, and remaining performance obligations rose 91% to $1.52 billion. Management also raised its full-year outlook to $2.99 billion to $3.03 billion in revenue and $6.39 to $6.58 in adjusted EPS.
Despite the beat-and-raise, the stock sold off sharply. Atlas revenue grew about 29% for the fifth consecutive quarter, a stable result that fell short of the roughly 30% to 31% acceleration some investors had priced in after the stock's strong pre-earnings run. Guidance implied a near-term slowdown, with third-quarter revenue growth of about 20.5% at the midpoint versus 30% in the second quarter. The stock's premium valuation and a large stock-based-compensation add-back also drew scrutiny. While several firms, including Barclays, Guggenheim, Goldman Sachs, and Canaccord, raised price targets after the print, the immediate market reaction treated the results as insufficient to justify the prior valuation. Shares partially rebounded around September 10 after CEO CJ Desai's upbeat commentary at a Citi technology conference.
The quarter's broader narrative was a recovery in software and data infrastructure names from early-year "SaaS disruption" fears tied to artificial intelligence. MongoDB shares bottomed near $294 in late June, then rallied sharply into mid-August as revenue growth reaccelerated above 30% and enthusiasm built around AI-driven data demand, with peers such as Datadog (DDOG) and Snowflake (SNOW) also rising. The stock reached roughly $473 before the September earnings report reset expectations, leaving the quarter's net gain near 5.7%. The reversal illustrates how quickly sentiment can shift when a high-multiple software name fails to show accelerating growth in its most closely watched metric.
Several factors are likely to shape MDB's trajectory. The company's Investor Day, scheduled for September 29, 2026, in New York, may provide updated detail on enterprise agreements and AI product momentum. Investors will also watch whether Atlas growth can reaccelerate as enterprise AI workloads move from experimentation to production, a point management has emphasized. Third-quarter results and updated guidance, competitive pressure from hyperscaler and database incumbents, and broader software-sector sentiment around AI spending will remain key. Macroeconomic conditions, including interest rates and enterprise IT budgets, could also influence the stock's high-multiple valuation. I'm watching this closely as the next few quarters could clarify whether the recent pullback was a temporary reset.
In my analysis of names like MongoDB, I often turn to Tickeron’s automated strategies to cross-check signals across different timeframes and market conditions. The Trending AI Robots page offers a curated selection of top-performing bots that trade thousands of tickers, allowing investors to compare approaches and performance metrics before deciding what might align with their goals. This can provide a clearer view of how AI-driven tools apply to current market setups without replacing manual review.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
With a background in economics and swing trading, I write about market trends, technical setups, momentum, and opportunities that develop over several days or weeks. I combine economic perspective with practical trading experience to explain why stocks move, what trends may be developing, and which market signals are worth watching.
On October 01, 2026, the Stochastic Oscillator for MDB moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 60 instances where the indicator left the oversold zone. In 51 of the 60 cases the stock moved higher in the following days. This puts the odds of a move higher at over 85%.
The Moving Average Convergence Divergence (MACD) for MDB just turned positive on October 09, 2026. Looking at past instances where MDB's MACD turned positive, the stock continued to rise in 36 of 43 cases over the following month. The odds of a continued upward trend are 84%.
Following a +6.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where MDB advanced for three days, in 234 of 299 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
The Momentum Indicator moved below the 0 level on September 28, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MDB as a result. In 66 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 77%.
MDB moved below its 50-day moving average on September 28, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for MDB crossed bearishly below the 50-day moving average on October 01, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 69%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MDB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
MDB broke above its upper Bollinger Band on September 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for MDB entered a downward trend on October 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. MDB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 68 (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 88 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 93 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.050) is normal, around the industry mean (17.861). P/E Ratio (471.380) is within average values for comparable stocks, (159.605). Projected Growth (PEG Ratio) (1.654) is also within normal values, averaging (3.648). Dividend Yield (0.000) settles around the average of (0.004) among similar stocks. P/S Ratio (11.025) is also within normal values, averaging (104.490).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MDB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a developer of MongoDB database
Industry ComputerCommunications